|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1997-11-28
|
|
pubmed:abstractText |
The purpose of the study is to investigate the efficacy of 1.0% apraclonidine in preventing intraocular pressure (IOP) spike after argon laser trabeculoplasty (ALT) in patients on chronic apraclonidine therapy compared with patients not on chronic apraclonidine use.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1921-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9373127-Adrenergic alpha-Agonists,
pubmed-meshheading:9373127-Aged,
pubmed-meshheading:9373127-Clonidine,
pubmed-meshheading:9373127-Female,
pubmed-meshheading:9373127-Glaucoma, Open-Angle,
pubmed-meshheading:9373127-Humans,
pubmed-meshheading:9373127-Intraocular Pressure,
pubmed-meshheading:9373127-Laser Therapy,
pubmed-meshheading:9373127-Male,
pubmed-meshheading:9373127-Ophthalmic Solutions,
pubmed-meshheading:9373127-Postoperative Complications,
pubmed-meshheading:9373127-Prospective Studies,
pubmed-meshheading:9373127-Trabeculectomy
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes.
|
|
pubmed:affiliation |
Kresge Eye Institute, Wayne State University, Detroit, Michigan 48201-1423, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
